Serum high sensitivity C-reactive protein is associated with carotid intima-media thickness in type 2 diabetes

Eun Seok Kang1, Hae Jin Kim, Yoo Mee Kim

  • 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. endohclee@yumc.yonsei.ac.kr

Insights

High sensitivity C-reactive protein (hsCRP) levels in type 2 diabetes patients correlate with cardiovascular disease risk factors and carotid intima-media thickness. This suggests hsCRP may help predict accelerated atherosclerosis in this population.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biochemistry

Background:

  • High sensitivity C-reactive protein (hsCRP) is a sensitive marker for cardiovascular disease risk.
  • Type 2 diabetes patients often exhibit elevated serum hsCRP levels compared to non-diabetic individuals.
  • Factors influencing hsCRP levels in type 2 diabetes require further investigation.

Purpose of the Study:

  • To evaluate the association between serum hsCRP levels and cardiovascular disease risk factors in type 2 diabetic subjects.
  • To determine the relationship between serum hsCRP levels and carotid intima-media thickness (IMT) in type 2 diabetes.

Main Methods:

  • 105 type 2 diabetes patients (excluding severe cardiovascular disease) underwent carotid ultrasonography for IMT assessment.
  • Serum hsCRP concentrations were measured in all participants.
  • Data analysis focused on correlations between hsCRP, IMT, and various risk factors.

Main Results:

  • Serum hsCRP levels showed significant correlations with carotid IMT (mean and maximal, left and right sides).
  • hsCRP also correlated with body mass index, waist circumference, waist-hip ratio, total cholesterol, triglycerides, and LDL cholesterol.
  • These findings indicate a link between inflammation, atherosclerosis, and metabolic factors in type 2 diabetes.

Conclusions:

  • Serum hsCRP levels are significantly correlated with carotid IMT in type 2 diabetic patients.
  • hsCRP is associated with multiple cardiovascular disease risk factors in this population.
  • Elevated hsCRP may serve as a predictor of accelerated atherosclerosis in individuals with type 2 diabetes.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.